X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs DIVIS LABORATORIES - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER DIVIS LABORATORIES PFIZER/
DIVIS LABORATORIES
 
P/E (TTM) x 31.9 31.6 101.2% View Chart
P/BV x 5.0 7.0 72.5% View Chart
Dividend Yield % 0.7 0.6 104.8%  

Financials

 PFIZER   DIVIS LABORATORIES
EQUITY SHARE DATA
    PFIZER
Mar-18
DIVIS LABORATORIES
Mar-18
PFIZER/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs2,3651,142 207.1%   
Low Rs1,625533 304.8%   
Sales per share (Unadj.) Rs430.3146.6 293.5%  
Earnings per share (Unadj.) Rs78.733.0 238.2%  
Cash flow per share (Unadj.) Rs93.238.4 242.6%  
Dividends per share (Unadj.) Rs20.0010.00 200.0%  
Dividend yield (eoy) %1.01.2 84.0%  
Book value per share (Unadj.) Rs586.5222.8 263.2%  
Shares outstanding (eoy) m45.75265.47 17.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.65.7 81.2%   
Avg P/E ratio x25.325.3 100.0%  
P/CF ratio (eoy) x21.421.8 98.2%  
Price / Book Value ratio x3.43.8 90.5%  
Dividend payout %25.430.3 84.0%   
Avg Mkt Cap Rs m91,271222,318 41.1%   
No. of employees `0002.610.8 24.4%   
Total wages/salary Rs m3,1434,561 68.9%   
Avg. sales/employee Rs Th7,484.83,616.0 207.0%   
Avg. wages/employee Rs Th1,195.0423.8 282.0%   
Avg. net profit/employee Rs Th1,369.1814.9 168.0%   
INCOME DATA
Net Sales Rs m19,68538,915 50.6%  
Other income Rs m1,1431,134 100.7%   
Total revenues Rs m20,82840,049 52.0%   
Gross profit Rs m5,00312,617 39.7%  
Depreciation Rs m6631,425 46.5%   
Interest Rs m413 31.6%   
Profit before tax Rs m5,47912,313 44.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,8783,543 53.0%   
Profit after tax Rs m3,6018,770 41.1%  
Gross profit margin %25.432.4 78.4%  
Effective tax rate %34.328.8 119.1%   
Net profit margin %18.322.5 81.2%  
BALANCE SHEET DATA
Current assets Rs m24,16745,351 53.3%   
Current liabilities Rs m9,5446,507 146.7%   
Net working cap to sales %74.399.8 74.4%  
Current ratio x2.57.0 36.3%  
Inventory Days Days55127 43.5%  
Debtors Days Days2995 30.2%  
Net fixed assets Rs m9,51421,160 45.0%   
Share capital Rs m458531 86.2%   
"Free" reserves Rs m26,37558,625 45.0%   
Net worth Rs m26,83259,156 45.4%   
Long term debt Rs m250-   
Total assets Rs m36,90067,832 54.4%  
Interest coverage x1,305.5926.8 140.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50.6 93.0%   
Return on assets %9.812.9 75.4%  
Return on equity %13.414.8 90.5%  
Return on capital %20.420.8 98.0%  
Exports to sales %00-   
Imports to sales %021.8 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA8,485 0.0%   
Fx inflow Rs m2232,359 0.1%   
Fx outflow Rs m1,4899,042 16.5%   
Net fx Rs m-1,46623,317 -6.3%   
CASH FLOW
From Operations Rs m3,3187,759 42.8%  
From Investments Rs m-2,383-4,783 49.8%  
From Financial Activity Rs m-1,104-3,142 35.1%  
Net Cashflow Rs m-169-166 101.5%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 11.8 63.6%  
FIIs % 4.9 19.0 25.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 17.2 137.8%  
Shareholders   85,207 31,796 268.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   CADILA HEALTHCARE  TTK HEALTHCARE  SHASUN PHARMA  STRIDES PHARMA SCIENCE  J.B.CHEMICALS  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 142 Points Higher; Metal and Healthcare Stocks Witness Buying(Closing)

Indian share markets continued their momentum during closing hours and ended the day on a positive note. Gains were largely seen in the metal sector and healthcare sector.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (3QFY19); Net Profit Up 68.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 68.9% YoY). Sales on the other hand came in at Rs 13 bn (up 29.4% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

DIVIS LABORATORIES 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, PFIZER has posted a net profit of Rs 958 m (down 13.8% YoY). Sales on the other hand came in at Rs 5 bn (down 9.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

How We Pick the Most Profitable Stocks from the Portfolios of Super Investors(The 5 Minute Wrapup)

Feb 8, 2019

This is the trick to following super investors and not losing money.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Feb 21, 2019 03:35 PM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS